C. Renou, B. Lesgourgues, G. Macaigne, A. Pauwels, Y. Le Bricquir, J. Henrion, F. Khemissa, E. Clair, T. Paupard, A. Pelaquier, H. Agostini, A.M. Roque-Afonso. Hepatitis E in decompensated alcoholic cirrhosis. Hepatology 2017 Jan;65(1):388-389. doi: 10.1002/hep.28792
H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017
P Ndumbi, G. S. Freidl, C. Williams, O. Mardh, C. Varela, A. Avellón, I. Friesema, H. Vennema, K. Beebeejaun , S. L. Ngui, M. Edelstein, A. Smith-Palmer, N. Murphy, J. Dean, M. Faber, J. Wenzel, M. Kontio, L. Müller, S. Midgley, L. Sundqvist, J. Ederth, A. Roque-Afonso, E. Couturier, S. Klamer, J. Rebolledo, V. Suin, S. W. Aberle, D. Schmid, R. de Sousa, G. F. Augusto, V. Alfonsi, M. Del Manso, A. Ciccaglione, K. Mellou, C. Hadjichristodoulou, A. Donachie, M. Borg, M. Sočan, M. Poljak, Ettore Severi and The European Hepatitis A outbreak team. Hepatitis A outbreak disproportionately affecting men who have sex with men (MSM) in the European Union and European Economic Area (EU/EEA), June 1st 2016 – May 31st 2017. Eurosurveill.
Alnuaimi K, Lavolé J, Lascoux-Combes C, Roque-Afonso AM, Sogni P, Pol S, Mallet V. Chronic hepatitis E in patients with indolent lymphoma after treatment with rituximab and bendamustine. Hepatology, 2017 Dec 1. doi: 10.1002/hep.29697. [Epub ahead of print].
Bisseux M, Colombet J, Mirand A, Roque-Afonso AM, Abravanel F, Izopet J, Archimbaud C, Peigue-Lafeuille H, Debroas D, Bailly JL, Henquell C. Monitoring human enteric viruses in wastewater and relevance to infections encountered in the clinical setting: results of a one-year experiment in Central France, 2014-2015. Eurosurveill. 2018 Feb;23(7). doi: 10.2807/1560-7917.ES.2018.23.7.17-00237
Charre C, Ramière C, Roque-Afonso AM, Chidiac C, Zoulim F, Godinot M, Koffi J, Scholtès C, Livrozet JM, HAV Lyon Study Group, Cotte L. HAV outbreak in French HIV-infected MSM and PrEP users despite a high immunization rate. Eurosurveill. Euro Surveill. 2017 Nov;22(48). doi: 10.2807/1560-7917.ES.2017.22.48.17-00742
Mallet V, Bruneau J, Zuber J, Alanio C, Leclerc-Mercier S, Roque-Afonso AM, Kraft ARM, Couronné L, Roulot D, Wedemeyer H, Albert ML, Hillon P, Laroche L, Pol S, Hermine O.Hepatitis E Virus-Induced Primary Cutaneous CD30(+) T cell Lymphoproliferative Disorder. J Hepatol. 2017 Aug 28. pii: S0168-8278(17)32250-X. doi: 10.1016/j.jhep.2017.08.011
Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V. Chronic hepatitis E in HIV/HBV coinfectde patient: lack of power of sofosbuvir-ribavirin. AIDS. 2017 Jun 1;31(9):1346-1348.
H Neffatti, P Lebraud, C Hottelet, J Gharbi, T Challouf, AM Roque-Afonso. Southern Tunisia: a still high endemicity area for Hepatitis A. PLoS One 2017 Apr 20;12(4):e0175887. doi: 10.1371/journal.pone.0175887. eCollection 2017.
S. Lhomme, L. Bardiaux, F. Abravanel, P. Gallian, N.Kamar, J. Izopet. Hepatitis E virus infection in solid organ transplant recipients, France. Emerging Infectious Diseases 2017;23:353-356.
M. Carré, A. Thiebaut-Bertrand, S. Larrat, V. Leroy, P. Pouzol, N. Sturm, S. Lhomme, JY. Cahn, F. Garban, P. Morand. Fatal autochthonous fulminant hepatitis E early after allogeneic stem cell transplantation. Bone Marrow Transplantation 2017;1-3.
Donnelly MC, SN. Imlach, F. Abravanel, S. Ramalingam, I. Johannessen, J. Petrik, AR. Fraser, JD. Campbell, P. Bramley, HR. Dalton, PC. Hayes, N. Kamar, KJ. Simpson. Sofosbuvir and Daclatasvir anti-viral therapy fails to clear HEV viremia and restore reactive T cells in a HEV/HCV co-infected liver transplant recipient. Gastroenterology 2017;152:300-301.
Abravanel F, S. Lhomme, M. Fougère, K. Sauné, M. Alvarez, JM. Péron, P. Delobel, J. Izopet. HEV infection in French HIV-infected patients. Journal of Infection 2017;74:310-313.
Abravanel F, N. Goutagny, C. Perret, S. Lhomme, F. Vischi, A. Aversenq, A. Chapel, N. Dehainault, N. Piga, J. Dupret-Carruel, J. Izopet. Evaluation of two VIDASÒ prototypes for detecting anti-HEV IgG. Journal of Clinical Virology 2017;89:46-60.
HR. Dalton, JJJ. Van Eijk, P. Cintas, RG. Madden, CJ. Jones, GW. Webb, B. Norton, J. Pique, S. Lutgens, N. Devooght-Johnson, K. Woolson, J. Baker, M. Saunders, L. Househam, J. Griffiths, F. Abravanel, J. Izopet, N. Kamar, N. van Alfen, BG. Van Engelen, JG. Hunter, AA. van der Eijk, RP. Bendall, BN. Mclean, BC. Jacobs. Hepatitis E virus infection and acute non-traumatic neurological injury: a prospective pilot multicentre study. Journal of Hepatology 2017;67:925-932.
J. Belliere, F. Abravanel, MB. Nogier, S. Martinez, P. Cintas, S. Lhomme, L. Lavayssière, O. Cointault, S. Faguer, J. Izopet, N. Kamar. Transfusion-acquired hepatitis E infection misdiagnosed as severe critical illness polyneuromyopathy in a heart-transplant patient. Transplant Infectious Disease 2017;19:6.
A Velay, W. Kack-Kack, F. Abravanel, S. Lhomme, P. Leyendecker, L. Kremer, P. Chamouard, J. Izopet, S. Fafi-Kremer, H. Barth. Parsonage-Turner syndrome due to autochthonous acute genotype 3f hepatitis E virus infection in a nonimmunocompromised 55-year-old patient. Journal of Neurovirology 2017;23:615-620.
S. Chapuy-Regaud, M. Dubois, C. Plisson-Chastang, T. Bonnefois, S. Lhomme, J. Bertrand-Michel, B. You, S. Simoneau, PE. Gleizes, B. Flan, F. Abravanel, J. Izopet. Characterization of the lipid envelope of exosome encapsulated HEV particles protected from the immune response. Biochimie 2017;141:70-79.
JJJ. van Eijk, HR. Dalton, P. Ripellino, RG. Madden, CJE. Jones, M. Fritz, C. Gobbi, G. Melli, E. Pasi, J. Herrod, RF. Lissmann, HH. Ashraf, M. Abdelrahim, O. Almasri, M. Fraga, D. Benninger, T. Kuntzer, V. Aubert, R. Sahli, D. Moradpour, H. Blasco-Perrin, S. Attarian, R. Gerolami, P. Colson, MT. Giordani, J. Hartl, S. Pischke, NX. Lin, BN. Mclean, RP. Bendall, M. Panning, JM. Peron, N. Kamar, J. Izopet, BC. Jacobs, N. van Alfen, BGM. van Engelen. Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international multicenter retrospective comparative study. Neurology 2017:909-917.
F. Abravanel, S. Lhomme, H. El Costa, B. Schvartz, JM. Peron, N. Kamar, J. Izopet. Rabbit Hepatitis E virus infections in humans, France. Emerging Infectious Diseases 2017;23:1191-1193.
H. Barragué, B. Condat, N. Petitdidier, E. Champagne, C. Renou, J. Izopet, F. Abravanel. Chronic hepatitis E virus infection in a cirrhotic patient: a case report. Medicine 2017;96 :e7915.
IM Sayed, L. Foquet, L. Verhoye, F. Abravanel, A. Farhoudi, G. Leroux-Roels, J. Izopet, P. Meuleman. Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma. Antiviral Research 2017 141:150-154.
IM. Sayed, L. Verhoye, L. Cocquerel, F. Abravanel, L. Foquet, C. Montpellier, Y. Debing, A. Farhoudi, C. Wychowski, J. Dubuisson, G. Leroux-Roels, J. Neyts, J. Izopet, T. Michiels, P. Meuleman. Study of Hepatitis E virus infection of genotype 1 and 3 in mice with humanized liver. Gut 2017;66:920-929.
N. Kamar, J. Izopet, N. Pavio, R. Agarwal, A. Labrique, H. Wedemeyer, H. Dalton. Hepatitis E virus infection. Nature Reviews Disease Primers 2017;3 :17086
X. Yin, X. Li, C. Ambardekar, Z. Hu, S. Lhomme, Z. Feng. Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog. 2017 May 30;13(5):e1006417.